Food and Drug Administration

  1. How NDAs Work and Why They're Important

    A non-disclosure agreement, or NDA, is a legal document that keeps the lid on sensitive ...
  2. Could Amgen's Next Drug Be Worth $100 Billion?

    Amgen hopes it will win an FDA green light for evolocumab, a next-generation cholesterol ...
  3. 3 Things That Could Hold Intuitive Surgical Back

    Taking a long-term view that favors Intuitive Surgical developer increasing in value, ...
  4. Did Orexigen Make A Big Mistake?

    Developing drugs isn't cheap. Drugmakers spend $1.4 billion in direct costs to bring ...
  5. Are These Biogen Idec's Next Blockbusters?

    Biogen Idec is already a company worth watching, but it’s recently launched hemophilia ...
  6. Why Does Wall Street Hate MannKind?

    Since peaking, MannKind's shares have tumbled 25% due in large part to Wall Street's ...
  1. Could Amgen's Next Drug Be Worth $100 Billion?

    Amgen hopes it will win an FDA green light for evolocumab, a next-generation cholesterol ...
  2. 3 Things That Could Hold Intuitive Surgical Back

    Taking a long-term view that favors Intuitive Surgical developer increasing in value, ...
  3. Did Orexigen Make A Big Mistake?

    Developing drugs isn't cheap. Drugmakers spend $1.4 billion in direct costs to bring ...
  4. Are These Biogen Idec's Next Blockbusters?

    Biogen Idec is already a company worth watching, but it’s recently launched hemophilia ...
  5. Why Does Wall Street Hate MannKind?

    Since peaking, MannKind's shares have tumbled 25% due in large part to Wall Street's ...
  6. What’s The Drug That Will Finally Fight Obesity?

    Orexigen just pulled back the curtain on interim results for a cardiac study that ...
  1. What are the major barriers to entry for new companies in the drugs sector?

    Find out why barriers to entry for U.S. drug companies are so high and how the Food and Drug Administration, or FDA, inhibits ...
  2. How does the strength of the IPO market affect the drugs sector?

    Discover how the strength of the IPO market affects the drugs sector. A strong IPO market reflects healthy risk appetites ...
  3. What does it mean that an investor faces binary outcomes when investing in drug companies?

    Learn why investments in biotech and drug companies can result in what are called binary outcomes, and understand why these ...
Trading Center